Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about BLOOD-BRAIN BARRIER: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | BLOOD-BRAIN BARRIER |
Knowledge base pages for this entity
graph TD
BLOOD_BRAIN_BARRIER["BLOOD-BRAIN BARRIER"] -->|"causes"| PARP1["PARP1"]
BLOOD_BRAIN_BARRIER["BLOOD-BRAIN BARRIER"] -->|"regulates"| CLDN5["CLDN5"]
BLOOD_BRAIN_BARRIER["BLOOD-BRAIN BARRIER"] -->|"causes"| ENDOTHELIAL["ENDOTHELIAL"]
BLOOD_BRAIN_BARRIER["BLOOD-BRAIN BARRIER"] -->|"causes"| STROKE["STROKE"]
BLOOD_BRAIN_BARRIER["BLOOD-BRAIN BARRIER"] -->|"impairs"| MICROGLIA["MICROGLIA"]
BLOOD_BRAIN_BARRIER["BLOOD-BRAIN BARRIER"] -->|"impairs"| ENDOTHELIAL_1["ENDOTHELIAL"]
ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"associated"| BLOOD_BRAIN_BARRIER["BLOOD-BRAIN BARRIER"]
MICROGLIA_2["MICROGLIA"] -->|"associated"| BLOOD_BRAIN_BARRIER["BLOOD-BRAIN BARRIER"]
NEURODEGENERATION["NEURODEGENERATION"] -->|"associated"| BLOOD_BRAIN_BARRIER["BLOOD-BRAIN BARRIER"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated"| BLOOD_BRAIN_BARRIER["BLOOD-BRAIN BARRIER"]
style BLOOD_BRAIN_BARRIER fill:#5d4400,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| PARP1 | co_discussed | entity | 0.50 |
| CLDN5 | co_discussed | entity | 0.50 |
| ENDOTHELIAL | co_discussed | entity | 0.50 |
| STROKE | co_discussed | entity | 0.50 |
| MICROGLIA | co_discussed | entity | 0.50 |
| TAU | co_discussed | entity | 0.50 |
| NEURON | co_discussed | entity | 0.50 |
| MACROPHAGE | co_discussed | entity | 0.50 |
| NEUROINFLAMMATION | co_discussed | entity | 0.50 |
| MACROPHAGES | co_discussed | entity | 0.50 |
| MONOCYTE | co_discussed | entity | 0.50 |
| COMPLEMENT | co_discussed | entity | 0.50 |
| SYNAPSE | co_discussed | entity | 0.50 |
| GFAP | co_discussed | entity | 0.50 |
| PI3K/AKT | regulates | pathway | 0.50 |
| SELEGILINE | associated_with | drug | 0.45 |
| KETAMINE | associated_with | drug | 0.45 |
| QUERCETIN | associated_with | drug | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| TRANSFERRIN RECEPTOR | mediates | entity | 0.95 |
| CLDN5 | involved_in | entity | 0.95 |
| DTG | inhibits | entity | 0.95 |
| OCLN | involved_in | entity | 0.95 |
| BRAIN ARTERIOVENOUS MALFORMATIONS | inhibits | entity | 0.95 |
| ER STRESS | inhibits | entity | 0.90 |
| PARP1 | regulates | entity | 0.85 |
| AGING | causes | entity | 0.85 |
| FCGRT | expressed_in | entity | 0.85 |
| DOLUTEGRAVIR | disrupts | compound | 0.80 |
| BBB | co_discussed | entity | 0.50 |
| AUTOPHAGY | co_discussed | entity | 0.50 |
| APOE | co_discussed | entity | 0.50 |
| ASTROCYTE | co_discussed | entity | 0.50 |
| APOPTOSIS | co_discussed | entity | 0.50 |
| ASTROCYTES | co_discussed | entity | 0.50 |
| AXON | co_discussed | entity | 0.50 |
| ALZHEIMER | co_discussed | entity | 0.50 |
| ALZHEIMER'S | co_discussed | entity | 0.50 |
| MICROGLIA | biomarker_for | cell_type | 0.50 |
| ASTROCYTES | biomarker_for | cell_type | 0.50 |
| NEURONS | biomarker_for | cell_type | 0.50 |
| OLIGODENDROCYTES | biomarker_for | cell_type | 0.50 |
| REMYELINATION | activates | process | 0.50 |
| STROKE | regulates | disease | 0.50 |
| PERICYTE | activates | cell_type | 0.50 |
| ALZHEIMER'S DISEASE | upregulates | disease | 0.50 |
| ALZHEIMER | upregulates | disease | 0.50 |
| ALZHEIMER'S DISEASE | causes | disease | 0.50 |
| ALZHEIMER | causes | disease | 0.50 |
| OXIDATIVE STRESS | causes | process | 0.50 |
| OXIDATIVE STRESS | associated_with | process | 0.50 |
| ASTROCYTE | regulates | cell_type | 0.50 |
| ASTROCYTE | activates | cell_type | 0.50 |
| MICROGLIA | activates | cell_type | 0.50 |
| CX43 | activates | gene | 0.50 |
| AGING | activates | process | 0.50 |
| STROKE | activates | disease | 0.50 |
| ASTROCYTE | associated_with | cell_type | 0.50 |
| MACROPHAGE | associated_with | cell_type | 0.50 |
| ALZHEIMER | regulates | disease | 0.50 |
| MACROPHAGES | activates | cell_type | 0.50 |
| GFAP | inhibits | gene | 0.50 |
| ALZHEIMER | associated_with | disease | 0.50 |
| NEURONS | activates | cell_type | 0.50 |
| NEURONS | associated_with | cell_type | 0.50 |
| PARKINSON | interacts_with | disease | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Optogenetic viral vector delivery via tFUS-mediated blood-br | 0.557 | Alzheimer's disease | Circuit-level neural dynamics in neurode |
| Blood-Brain Barrier SPM Shuttle System | 0.550 | neurodegeneration | Neuroinflammation resolution mechanisms |
| GAS6/TAM Axis Activation Stabilizes Blood-Brain Barrier to R | 0.498 | neuroinflammation | Why do TAM receptors protect against neu |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-16 | 0 hypotheses
neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.499
neuroinflammation | 2026-04-13 | 0 hypotheses
neurodegeneration | 2026-04-12 | 2 hypotheses Top: 0.537
neurodegeneration | 2026-04-12 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Genome-Scale Meta-analysis of Host Responses to Staphylococcus aureus Identifies [PMID:40447280] | Russell CD, Goeldner-Thompson S, Smith E | J Infect Dis | 2025 | 1 |
| An AAV capsid reprogrammed to bind human transferrin receptor mediates brain-wid [PMID:38753766] | Huang Q, Chan KY, Wu J, Botticello-Romer | Science | 2024 | 1 |
| Targeting the transferrin receptor to transport antisense oligonucleotides acros [PMID:39141703] | Barker SJ, Thayer MB, Kim C, Tatarakis D | Sci Transl Med | 2024 | 1 |
| Blood-brain barrier transport using a high affinity, brain-selective VNAR antibo [PMID:33241587] | Stocki P, Szary J, Rasmussen CLM, Demydc | FASEB J | 2021 | 1 |
| Transferrin receptor 1 in cancer: a new sight for cancer therapy. [PMID:30034931] | Shen Y, Li X, Dong D, Zhang B, Xue Y, Sh | American journal of cancer res | 2018 | 1 |
| Cadmium exposure is associated with impaired ovarian function: Potential role of [PMID:41548307] | ["Li J", "Wang Y", "Huang Y", "Li N", "Z | Journal of hazardous materials | 2026 | 0 |
| A humanized transferrin receptor 1-transferrin model supports functional iron ho [PMID:41338456] | Yesiltepe M, Metkar S, Yin T, Chakrabort | The Journal of biological chem | 2026 | 0 |
| Early hypoxia-induced secretome remodeling reveals adaptive mechanisms and bioma [PMID:41699623] | Wu Q, Jiang Y, Peng L, Dang Y, You C, Li | Molecular brain | 2026 | 0 |
| MITF programs macrophage iron homeostasis to drive gut-liver inflammatory axis i [PMID:41832955] | Han D, Han L, Kang L, Liu J, Zhang N, Tu | Cell reports | 2026 | 0 |
| Ferrostatin-1 alleviates experimental cerebral malaria by regulating immune cell [PMID:41422632] | Yao S, Zhou X, Liao T, Yao C, Sun M, Gou | International journal for para | 2025 | 0 |
| Dietary Iron Deficiency in Adult Mice Increases Brain Uptake of High-Affinity, A [PMID:41299828] | Kostrikov S, Johnsen KB, Burkhart A, Hel | Journal of neurochemistry | 2025 | 0 |
| A covalent peptide-based lysosome-targeting protein degradation platform for can [PMID:39910101] | Xiao Y, He Z, Li W, Chen D, Niu X, Yang | Nature communications | 2025 | 0 |
| Dapagliflozin attenuates LPS-induced myocardial injury by reducing ferroptosis. [PMID:38743190] | ["Hu K", "Jiang P", "Hu J", "Song B", "H | Journal of bioenergetics and b | 2024 | 0 |
| Ferroptosis promotes valproate-induced liver steatosis in vitro and in vivo. [PMID:39147356] | ["Yan X", "Ma L", "Chen X", "Ren J", "Zh | Food and chemical toxicology : | 2024 | 0 |
| TfR-conjugated nanoparticles achieve 50-fold increase in brain delivery vs free [PMID:synthetic_13] | Unknown | ACS Nano | 2023 | 0 |
| Specialized pro-resolving mediators reduce brain inflammation and amyloid pathol [PMID:synthetic_9] | Unknown | Nature Med | 2023 | 0 |
| TfR saturation limits uptake of targeting ligands at physiological transferrin c [PMID:synthetic_15] | Unknown | Mol Pharm | 2022 | 0 |
| Deficiency of pro-resolving lipid mediators in Alzheimer's disease brain and cer [PMID:synthetic_10] | Unknown | JAMA Neurol | 2022 | 0 |
| Resolvin D1 promotes microglial phagocytosis and suppresses inflammatory cytokin [PMID:synthetic_11] | Unknown | J Neuroinflammation | 2021 | 0 |
| High-dose SPM analogs cause off-target immunosuppression in sepsis models [PMID:synthetic_14] | Unknown | Crit Care Med | 2021 | 0 |